Wu W, et al. - In this study, researchers estimated the relationship between progressive skin fibrosis and visceral organ progression and mortality during follow-up in subjects with diffuse cutaneous systemic sclerosis (dcSSc) among 1021 candidates. They found that skin progressors had significantly higher chances of FVC decline ≥10% (53.6% vs 34.4%) and all-cause death (15.4% vs 7.3%) as compared to non-progressors. They reported that such significant relations were observed in individuals with either low baseline modified Rodnan skin score (mRSS) (≤22/51) or short disease duration (≤15 months). They concluded mRSS as a surrogate marker in dcSS.